Clinical Heart and Vascular Center
Physician Update 2018
Explore Physician Update 2018:
- My Top 5 Takeaways
- Effects of Linagliptin on Heart Failure and Related Outcomes: Observations from the CARMELINA Trial
- Prevention Beyond the Guidelines
- The Intersection of Cancer and Cardiovascular Disease
- Left Ventricular Hypertrophy, Subclinical Myocardial Injury, and Risk of Heart Failure Among African-Americans
- Clinical Awards: Drazner Receives 2018 Laennec Master Clinician Award
- AFib and HFrEF: The Great Debates
- Financial Toxicity from Health Care Expenditures in Patients with ASCVD
- Hot Topics in Structural Heart Disease
- Update on Non-ST-Elevation Acute Coronary Syndromes
- The Emerging Science in Valvular Heart Disease
- Prognosis in Heart Failure and Shock
- 2018 ‘Guideline on Evaluation and Management of Patients with Bradycardia and Conduction Delay’ – What You Need to Know
- Groundbreaking Studies in the Practice of Cardiovascular Medicine from the AHA 2018 Circulation Symposium
- UTSW Has ‘Influential’ Social Media Presence at 2018 AHA Sessions
- Randomized Controlled Trial of ECG Screening in Young Athletes: Necessary, Yes – Feasible, Maybe
- Mechanistic Insights into Duchenne Muscular Dystrophy-Associated Cardiomyopathy
- HDL Efflux and GlycA
- Exercise Harm vs. Help: Is There a Goldilocks-Like Sweet Spot?
- Using Coronary Artery Calcium as a Tie-Breaker in Prevention
- Is Heart Failure with Preserved Ejection Fraction an Obesity Disease?
- Advances in the Care of Stage D Heart Failure: LVAD/Transplant